| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | AC | AD | AE | AF | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | SENARAI UBAT TERKAWAL HOSPITAL SULTAN IDRIS SHAH, SERDANG | ||||||||||||||||||||||||||||||||
2 | Bil | Nama Ubat | Jenama | Monitor | Kelas Ubat | Jabatan | Lulus masuk formulari | Perubahan kuota pada | Kuota terkini (Setahun) | Kuantiti ubat/Catatan | |||||||||||||||||||||||
3 | (A) | ||||||||||||||||||||||||||||||||
4 | 1 | Abacavir sulphate 300mg tablet | OP | A* | Perubatan Am | JKUT 02/2022 | JKUT 1/2024 (+20) | 25 pesakit | 600mg ON. 5 patients at one time | ||||||||||||||||||||||||
5 | 2 | Abacavir Sulphate 600mg and Lamivudine 300mg Tablet | OP | A* | Perubatan Am (ID) | JKUT 02/2023 (+5) | JKUT 1/2025 (+5) | 10 pesakit | 1 tab OD | ||||||||||||||||||||||||
6 | 3 | Abiraterone 250mg Tablet | OP | A* | Urologi | JKUT 1/2024 (+5) JKUT 1/2025 (+5) JKUT 1/2026 (LUAR JKUT +5) | 15 pesakit | 1000mg od Yusof Bin Rahmat (2021)SD01234952 MARIAPPAN PERIANAN (SD1134662) (2021) JAAFAR BIN CHIK SD00728980 (2022) MUSLIM BIN MOHAMAD DIN SD01090188 (2023) Abdul Rahaman bin Awang (SD1293117) | |||||||||||||||||||||||||
7 | 4 | Acalabrutinib 100mg Film Coated Tablet | Calquence | OP | A* | Medical (Hematology) | Luar JKUT 2/2026 | Luar JKUT 2/2026 (1) | 1 pesakit | 6 Bulan sahaja | |||||||||||||||||||||||
8 | 5 | Acitretin 10mg Capsule | Novatretin | OP | A* | Dermatology | JKUT 1/16 | JKUT 1/16 (4) JKUT 1/17 (5) JKUT 1/2021 (7) JKUT 1/2024 (+8) | 30 pesakit | ||||||||||||||||||||||||
9 | 6 | Acitretin 25mg Capsule | Novatretin | OP | A* | Dermatology | JKUT1/16 | JKUT 1/17 (5) JKUT 1/18 (5) JKUT 1/2021 (10) JKUT 1/2024 (10) JKUT 1/2025(+30) JKUT 1/2026 (LUAR JKUT -10) | 50 pesakit | ||||||||||||||||||||||||
10 | 7 | Adalimumab 40mg PFS Inj | Humira | OP | A* | Medical (GASTRO) | JKUT 1/11 | JKUT 02/2022 (+10) GASTRO JKUT 1/2024 (+5) JKUT 1/2025 (+5) | GASTRO: 20 Pesakit | ||||||||||||||||||||||||
11 | Medical (RHEUMATOLOGY) | JKUT 1/23 | JKUT 1/2023 (+2) RHEUMATOLOGY JKUT 2/2023 (+1) JKUT 1/2024 (+5) JKUT 1/2025 (+5) | RHEUMATO: 13 Pesakit | |||||||||||||||||||||||||||||
12 | 8 | Adapalene 0.1% cream | Differin | OP | A* | Dermatology | JKUT 1/08 | JKUT 1/08 (100) JKUT 1/2025 (+200 tubes) | 300 tiub | ||||||||||||||||||||||||
13 | 9 | Agomelatine 25mg Tablet | Valdoxan | OP | A* | Psychiatry | JKUT 1/2022 (+2) | JKUT 1/2023 (+5) JKUT 1/2024 (+8) JKUT 1/2025 (+35) JKUT 2/2025 (+10) JKUT 1/2026 (+30) | 90 pesakit | Prescribing restriction: For patients who are unable to tolerate SSRIs as it increases risk of bleeding especially in elderly or patients who are on anticoagulant Dose: 25-50mg OD 1-2 tab OD/pesakit. Total: 365-730 tab/tahun | |||||||||||||||||||||||
14 | 10 | Alendronate Sodium 70 mg & Cholecalciferol 5600 IU Tab | Fosamax Plus | OP | A* | Medical (Reumatologi) | JKUT 3/14 (20) | JKUT 1/2022 (+10) JKUT 1/2023(+20) JKUT 1/2024 (+50) JKUT 1/2025 (+50) JKUT 1/2026 (PINDAH KUOTA) | 150 pesakit | 1 tab weekly for 52 weeks Pindah kuota dari Reumato ke Perubatan AM | |||||||||||||||||||||||
15 | 11 | Alfacalcidol Drops 2mcg/ml | One-alpha | OP | A* | Paediatric | JKUT 1/10 | JKUT 1/17 (-5) JKUT 1/18 (5) JKUT 1/19 (+5) | 15 pesakit | NEONATE: 0.1MCG/KG OD CHILD: 0.05MCG/KG OD | |||||||||||||||||||||||
16 | NA | Nephrology | JKUT 3/10 | 1 pesakit | Tiada pesakit aktif. | ||||||||||||||||||||||||||||
17 | 12 | Alfacalcidol 2mcg/ml Injection | One-alpha | IP | A* | Nephrology | JKUT 2/19 (+3) | JKUT 02/2022 (+2) | 5 Pesakit | 1-2 vials three times per week/patient Lifelong | |||||||||||||||||||||||
18 | 13 | Alfuzosin HCl 10mg Tablet | OP | A* | Medical (Geriatrik) | JKUT 1/2026 (LUAR JKUT +10) | 10 pesakit | ||||||||||||||||||||||||||
19 | 14 | Allopurinol 100mg Tablet | OP | A/KK | Medical | JKUT 1/2022 (+20) | JKUT 02/2022 (OPEN) | OPEN | Initial dose: 50-100 mg daily. Maintenance: 300-900mg daily (depending on renal function). | ||||||||||||||||||||||||
20 | 15 | All-Trans Retinoic Acid (Tretinoin) 10 mg Capsule | Vesanoid | OP | A* | Medical (Haematology) | JKUT 2/2023 (+5) | 5 pesakit | 45 mg/m2 daily for 30 - 90 days. | ||||||||||||||||||||||||
21 | 16 | Alteplase 50mg Injection | TPA-Activase | IP | A* | Paed Cardiology | JKUT1/19 (+1) | JKUT 1/2024 (+3) | 4 pesakit | 2 vials/patient each time according to patient's condition | |||||||||||||||||||||||
22 | Pulmonology | JKUT 1/2026 (LUAR JKUT +4 vial per year) | 4 vial per year | ||||||||||||||||||||||||||||||
23 | Kecemasan | JKUT 1/2026 (+6 vial) | 6 vial | ||||||||||||||||||||||||||||||
24 | 17 | Amisulpride 100mg & 400mg Tablet | SOLIAN | OP | A* | Psychiatry | JKUT 2/2021 (+2) | JKUT 02/2022 (+2) JKUT 1/2024 (+5) JKUT 2/2024 (+11) JKUT 2/2025 (+10) JKUT 1/2026 (LUAR JKUT +10) | 30 pesakit | Prescribing Restriction: For pts who are unable to tolerate atypical antipsychotic drugs | |||||||||||||||||||||||
25 | 18 | Amlodipine 10mg & Valsartan 160mg Tablet | Exforge | OP | A* | Cardiology | JKUT 3/09 | JKUT 3/18 (+10) JKUT 2/19 (+15) JKUT 1/2024 (+50 combined with Amlodipine/Valsartan 5/160mg) JKUT 1/2026 (LUAR JKUT OPEN) | OPEN | 1 pesakit = 365 tab/tahun. Total = 16200 tabs | |||||||||||||||||||||||
26 | Nephrology | JKUT 3/09 | JKUT 1/2026 (LUAR JKUT OPEN) | OPEN | 1 pesakit = 365 tab/tahun. Total = 10950 tabs | ||||||||||||||||||||||||||||
27 | Medical | JKUT 3/13 | JKUT 1/15 JKUT 2/15 (10) JKUT 1/17 (3) JKUT 1/18 (15) JKUT 3/18 (+15) JKUT 1/2026 (LUAR JKUT OPEN) | OPEN | 1 TAB OD 1 pesakit = 365 tab/tahun. Total = 5475 tabs/tahun | ||||||||||||||||||||||||||||
28 | 19 | Amlodipine 5mg & Valsartan 160mg Tablet | Exforge | OP | A* | Cardiology | JKUT 3/09 | JKUT 3/18 (+10) JKUT 1/2024 (+50 combined with Amlodipine/Valsartan 5/160mg) JKUT 1/2026 (LUAR JKUT OPEN) | OPEN | 1 pesakit = 365 tab/tahun. Total = 9000 tabs | |||||||||||||||||||||||
29 | Nephrology | JKUT 3/09 | JKUT 3/15 (9) JKUT 1/2026 (LUAR JKUT OPEN) | OPEN | 1 pesakit = 365 tab/tahun. Total = 5475 tabs | ||||||||||||||||||||||||||||
30 | Medical | JKUT 3/13 | JKUT 1/15 JKUT 1/17 (total 45) JKUT 1/2025 (60) JKUT 1/2026 (LUAR JKUT OPEN) | OPEN | 1 pesakit = 365 tab/tahun. Total = 5475 tabs/tahun | ||||||||||||||||||||||||||||
31 | 20 | Amorolfine 5% Nail Lacquer | Loceryl | OP | A* | Dermatology | JKUT 2/2023 (+150) | JKUT 3/2025 (+ 150) | 300 pesakit | 2-4 bottles per patient | |||||||||||||||||||||||
32 | 21 | Apixaban 2.5mg Tablet | Eliquis | OP | A* | Cardiology | JKUT 1/17 | JKUT 1/18 (10) JKUT 3/18 (SHARING STRENGTH) JKUT 1/19 (+10) JKUT 2/19 (+15) JKUT 1/20 (+10) JKUT 2/20 (+20) JKUT 2/2021 (+30) JKUT 1/2023 (+5) JKUT 1/2024 (+50) JKUT 2/2024 (Apixaban 2.5mg +30pt; Apixaban 5mg +70pt) JKUT 1/2025 ((Apixaban 2.5mg +68pt; Apixaban 5mg +76pt) JKUT 1/2026 (SHARING STRENGTH) (OPEN 1000) | 173 pesakit OPEN | 1 tab bd | |||||||||||||||||||||||
33 | Medical (Geriatrik) | JKUT 2/2025 | JKUT 2/2025 (+10) | 10 pesakit | |||||||||||||||||||||||||||||
34 | Nephrology | JKUT 1/2022 (+5 SHARING STRENGTH) | JKUT 1/2024 (+5) JKUT 1/2025(+5) | Jumlah untuk 2.5mg & 5mg = 20 pesakit | |||||||||||||||||||||||||||||
35 | 22 | Apixaban 5mg Tablet | Eliquis | OP | A* | Cardiology | JKUT 1/17 | JKUT 1/18 (10) JKUT 3/18 (SHARING STRENGTH) JKUT 1/19 (+10) JKUT 2/19 (+15) JKUT 1/20 (+10) JKUT 2/20 (+20) JKUT 2/2021 (+30) JKUT 1/2023 (+5) JKUT 2/2023 (+50) JKUT 1/2024 (+50) JKUT 2/2024 (Apixaban 2.5mg +30pt; Apixaban 5mg +70pt) JKUT 1/2025 (Apixaban 2.5mg +68pt; Apixaban 5mg +76pt) JKUT 1/2026 (SHARING STRENGTH) (OPEN 1000) | 300 pesakit OPEN | 1 tab bd | |||||||||||||||||||||||
36 | Medical | JKUT 2/17 (3) | JKUT 1/18 (17) JKUT 1/2025 (50) JKUT 1/2026 (LUAR JKUT +30) | 80 pesakit | 1 tab bd | ||||||||||||||||||||||||||||
37 | Nephrology | JKUT 1/2022 (+5 SHARING STRENGTH) | JKUT 1/2024 (+5) JKUT 1/2025(+5) | Jumlah untuk 2.5mg & 5mg = 20 pesakit | |||||||||||||||||||||||||||||
38 | Pulmonology | JKUT 1/2026 (LUAR JKUT +20) | 20 pesakit | ||||||||||||||||||||||||||||||
39 | 23 | Aripiprazole 10mg & 15mg Tablet | Abilify | OP | A* | Psychiatry | JKUT 1/12 | JKUT 2/15 (3) JKUT 1/17 (5) JKUT 1/19 (+5) JKUT 1/20 (+6) JKUT 2/2021 (+5) JKUT 2/2022 (+10) JKUT 1/2024 (+39) JKUT 2/2024 (OPEN) | OPEN | 10-30mg OD / pt | |||||||||||||||||||||||
40 | 24 | Asenapine 10mg Sublingual Tablet | Saphris | OP | A* | Psychiatry | JKUT 1/20 | JKUT 1/2021 (1) JKUT 2/2023 (+3) | 5 pesakit | ||||||||||||||||||||||||
41 | 25 | Artemether & Lumefantrine Tablet | Riamet | IP | A* | Medical | JKUT 1/10 | 5 pesakit | Pembelian mengikut penggunaan. | ||||||||||||||||||||||||
42 | 26 | Ascorbic acid 100mg Tablet | IP | C+ | Farmasi | JKUT 1/2021 | 240 pesakit | Dose 2g OD for COVID-19 patients in ICU setting. Open for Dental dept | |||||||||||||||||||||||||
43 | 27 | Atazanavir 300mg Capsule | OP | A* | Medical (ID) | JKUT 1/2025 (2) | JKUT 2/2025 (+8) | 10 pesakit | |||||||||||||||||||||||||
44 | 28 | Azelaic Acid 20% Cream | OP | A* | Dermatology | JKUT 1/2024 | JKUT 1/2024 (+100) | 100 pesakit | Duration up to 6/12 | ||||||||||||||||||||||||
45 | 29 | Azelastine Hydrochloride 137mcg & Fluticasone Propionate 50mcg Nasal Spray | Dymista | OP | A* | ENT | JKUT 1/2021 (10) | JKUT 2/2022 (+20) JKUT 1/2026 (LUAR JKUT +20) | 50 pesakit | Prescribing Restrictions: Prescribed by ENT specialists/ consultant | |||||||||||||||||||||||
46 | (B) | ||||||||||||||||||||||||||||||||
47 | 30 | Baricitinib 4mg film-coated tablets | OP | A* | Medical (RHEUMATOLOGY) | JKUT 2/2023 (3) | JKUT 1/2024 (+1) JKUT 2/2024 (+2) JKUT 1/2025 (+2) | 8 pesakit | To be prescribed by Rheumatologist only 4mg OD | ||||||||||||||||||||||||
48 | Dermatology | JKUT 2/2024 (+1) | 1 pesakit | ||||||||||||||||||||||||||||||
49 | 31 | Beclomethasone 100 mcg and formoterol fumarate dehydrate 6 mcg pressurized inhalation solution (FOSTER) | Foster | OP | A | Pulmonology | JKUT 3/14 | JKUT 1/18 (30) JKUT 1/20 (20) JKUT 02/2022 (+5) JKUT 1/2023 (+20) 27.7.2023: (+25) JKUT 2/2024 (+50) JKUT 2/2024 (+50) JKUT 2/2025 (+30) JKUT 1/2026 (+60) | 390 pesakit | ONLY BY PULMONOLOGY DEPT | |||||||||||||||||||||||
50 | 32 | Benralizumab 30mg Solution for Injection in Prefillied Pen | IP | A* | Pulmonary | JKUT 1/2025 (5pt) | JKUT 2/2025 (+5) JKUT 1/2026 (+3) | 13 pesakit | as per min mesy pre-JKUT bil1/2025 | ||||||||||||||||||||||||
51 | 33 | Benzydamine HCl 3.0mg/ml Throat Spray | Difflam Forte | OP | A* | ENT | JKUT 3/13 | JKUT 1/17 (150) JKUT 1/2025 (+150) JKUT 1/2026 (LUAR JKUT +50) | 450 botol | 1bott/pesakit | |||||||||||||||||||||||
52 | Dental | JKUT 1/16 (24) | JKUT 1/2024 (200 bottle/year) | 200 bottles/year (total) | 1bott/pesakit | ||||||||||||||||||||||||||||
53 | Paediatric Dental | JKUT 1/16 (10) | 0 | Mansuh JKUT 1.2024 | |||||||||||||||||||||||||||||
54 | 34 | Bimatoprost 0.01% ophthalmic solution | Lumigan | OP | A* | Ophtalmology | 4/1/2024 | JKUT 1/2025 (+4) | 5 pesakit | SD01311356 - Mohd Zuki Bin Ali, Tan Sri Dato Seri | |||||||||||||||||||||||
55 | 35 | Bleomycin 15mg Injection | Bleocin | IP | A* | Medical (Hematology) | JKUT 1/2024 | JKUT 1/2024 (+5) JKUT 1/2026 (LUAR JKUT MANSUH) | 0 Pesakit | Mansuh dari Item Jabatan | |||||||||||||||||||||||
56 | Bleocin | IP | A* | Ophtalmology | JKUT 1/2024 | JKUT 1/2024 (+50 bottle/year) JKUT 1/2025(-40 bottle/year) JKUT 1/2026 (LUAR JKUT -5 vial) | 5 vials | ||||||||||||||||||||||||||
57 | Bleocin | IP | A | ENT | JKUT 2/18 | 10 pesakit | 1-2 vial/pesakit/tahun | ||||||||||||||||||||||||||
58 | 36 | Bortezomib 3.5mg Injection | IP | A* | Medical (Hematology) | JKUT 1/2024 | JKUT 1/2024 (+4) | 4 pesakit | |||||||||||||||||||||||||
59 | 37 | Bosentan 125mg Tab | Tracleer | OP | A* | Cardiology | JKUT 1/11 (2) | JKUT 2/19 (+2) JKUT 2/2021 (+3) JKUT 1/2022 (+1) JKUT 1/2023 (+3) JKUT 2/2023 (+2) JKUT 1/2024 (+5) JKUT 1/2025 (+57) JKUT 1/2026 (+75) | 150 pesakit | ||||||||||||||||||||||||
60 | Pulmonology | JKUT 1/19 (+5) | JKUT 1/2022 (+3) JKUT 1/2023(+3) JKUT 2/2023 (+4) JKUT 1/2024 (+10) JKUT 1/2025 (+10) | 35 Pesakit | Patients are transferred from Hospital Ampang Lung Transplant Clinic in 2019. | ||||||||||||||||||||||||||||
61 | Paediatric Cardiology | JKUT 1/2022 (+2) | JKUT 2/2023 (+1) JKUT 1/2024 (+27) JKUT 1/2025 (+25) | 55 pesakit | |||||||||||||||||||||||||||||
62 | 38 | Brimonidine Tartrate 0.15% ophthalmic solution | Alphagan | OP | A* | Ophtalmology | JKUT 2/08 | JKUT 1/17 JKUT 1/18 (3000) JKUT 2/18 (+960 Botts) JKUT 1/20 (60 pt = 1440 bottles) JKUT 2/2023 (+50) JKUT 1/2025 OPEN QUOTA | OPEN QUOTA | 2 botts/pt/month | |||||||||||||||||||||||
63 | 39 | Brinzolamide 1% and Brimonidine tartrate 0.2% ophthalmic suspension | Simbrinza | OP | A* | Ophtalmology | JKUT 1/20 | JKUT 2/2023 (+42) JKUT 1/2025(+10) JKUT 1/2026 (LUAR JKUT +10) | 70 pesakit | 1) Reserved for patients who are already on both Brimonidine and Dorzolamide eye drops, 2) prescribed by Ophthal specialists 3) 1 drop bd (1 bott/pt/month) | |||||||||||||||||||||||
64 | 40 | Budesonide 160mcg + Formoterol 4.5mcg Inhalation | Rapihaler | OP | A | Paediatrik | JKUT 1/24 (10) | JKUT 1/2025 (30) JKUT 1/2026 (LUAR JKUT +10) | 50 pesakit | ||||||||||||||||||||||||
65 | Symbicort | OP | A | Paediatrik | JKUT 1/24 (5) JKUT 1/2025 (5) JKUT 1/2026 (LUAR JKUT +20) | 30 pesakit | |||||||||||||||||||||||||||
66 | Symbicort | OP | A | Pulmonology | JKUT 2/08 | JKUT 1/14 JKUT 1/15 JKUT 3/15 (50) JKUT 1/18 (PULMONOLOGY ONLY) JKUT 2/19 (+20) JKUT 1/2023 (20) JKUT 2/2023 (+50) JKUT 1/2025 (open quota) JKUT 1/2026 (+200) | open quota ke 600pt 800 pesakit | 1 pesakit = 12 can/tahun (either strength). Total = 3600 cans/tahun ONLY BY PULMONOLOGY DEPT | |||||||||||||||||||||||||
67 | 41 | Budesonide / Glycopyrronium / Formoterol fumarate dihydrate 160 / 7.2 / 5 mcg per actuation Pressurised Inhalation Suspension | A* | Pulmonologi | JKUT 1/2026 (+25) | 25 pesakit | |||||||||||||||||||||||||||
68 | 42 | Bumetanide 1mg Tablet | OP | A* | Pulmonology | JKUT 2/2025 | JKUT 2/2025 (+5) | 5 pesakit | |||||||||||||||||||||||||
69 | (C) | ||||||||||||||||||||||||||||||||
70 | 43 | Cabergoline 0.5mg Tablet | Dostinex | NA | A* | O & G | JKUT 2/11 | JKUT 2/11 | Buka kepada pesakit O&G | ||||||||||||||||||||||||
71 | OP | Medical | JKUT 2/12 | JKUT 2/19 (+2) JKUT 1/20 (+5) JKUT 1/2024 (Open Quota) | Open quota | 1 patient = 1 tab 2 x week | |||||||||||||||||||||||||||
72 | 44 | Calcipotriol 50 mcg/g & Ointment | Daivonex | OP | A* | Dermatology | JKUT 1/19 (+40 Tubes) | JKUT 1/2025 (+100 tubes) JKUT 2/2025 (-40 tubes) JKUT 1/2026 (LUAR JKUT MANSUH FORMULARI HSIS) | 0 TUBES | MANSUH UBAT DARI FORMULARI HSIS. HABISKAN STOK SEDIA ADA | |||||||||||||||||||||||
73 | 45 | Calcipotriol 50 mcg/g & Betamethasone Dipropionate 0.5 mg/g Ointment | Daivobet | OP | A* | Dermatology | JKUT 1/08 | JKUT 2/2025 (+100 tubes) JKUT 1/2026 (LUAR JKUT +80 tubes) | 520 tubes | 1 pt = 10 tubes/tahun. Total = 540 tubes/tahun | |||||||||||||||||||||||
74 | 46 | Calcipotriol Monohydrate 50mcg/g & Betamethasone Dipropionate 0.5mg/g Cutaneous Foam | Enstilar | OP | A* | Dermatology | JKUT 02/2023 (150bott) | JKUT 1/2026 (LUAR JKUT +30) | 280 botol | 1 bottle / 3months | |||||||||||||||||||||||
75 | 47 | Calcipotriol 50 mcg/g & Bethamethasone Dipropionate 0.5mg/g Gel | Xamiol | OP | A* | Dermatology | JKUT 1/13 | JKUT 1/2026 (LUAR JKUT +90 tubes) | 30 pesakit 450 tubes | 360 tubes 1 pt = 12 tube/tahun. Total = 360 tubes/tahun | |||||||||||||||||||||||
76 | 48 | Calcitonin (synthetic Salmon) 100 IU Injection | IP | A* | Medical | JKUT 1/2024 | JKUT 1/2024 (+5) | 5 pesakit | 200IU TDS x 3 days | ||||||||||||||||||||||||
77 | 49 | Calcitriol 1 mcg/ml injection | Bonky | IP | A* | Nefrology | Luar JKUT 2/2026 | Luar JKUT 2/2026 (+1: 100 amp) | 1 pesakit (100amp) | ||||||||||||||||||||||||
78 | 50 | Cal Chloride Dihydrate, Sodium Chloride, Mag Chloride Hexahydrate, Sod Acetate Trihydrate,Pot Chloride, and Malic Acid Solution 500mL Inj | sterofundin | IP | A | Anestesiology | JKUT 3/13 | JKUT 1/2026 (LUAR JKUT OPEN) | OPEN | 1 pesakit = 1 unit. Total = 400 vials/tahun. Pembelian mengikut penggunaan. | |||||||||||||||||||||||
79 | 51 | Calfactant 35mg/ml intratracheal suspension | Infasurf | IP | A | Paediatrik | JKUT 1/18 | JKUT 2/2025 (+20) | 100 bott | 3ml/kg, 12 hours apart. Up to 3 doses | |||||||||||||||||||||||
80 | 52 | Carbetocin 100mcg/ml Injection | Duratocin | IP | A* | O&G | JKUT 3/13 (100) | JKUT 2/19 (+75) JKUT 2/2022 (+100) 27.11.2023 (OPEN) | OPEN | Kawalan dalaman Jab O&G (Consultant & Specialist Only) 27.11.2023: Kuota buka kepada Jabatan O&G. Pembelian mengikut penggunaan | |||||||||||||||||||||||
81 | 53 | Carboplatin 450 mg Injection | Paraplatin | IP | A* | O&G | JKUT 1/17 | JKUT 1/18 (3) JKUT 1/19 (+6) | 21 pesakit | Every 3 weekly for 6 cycles (2 vials/pt) | |||||||||||||||||||||||
82 | 54 | Cefazolin Sodium 1 g injection | Sandoz | IP | A | CTC | JKUT 1/20 (OPEN) | OPEN | JKUT 1/20: Open to all department | ||||||||||||||||||||||||
83 | 55 | Ceftazidime 2g & Avibactam 0.5g Injection | IP | A* | Medical (ID) | JKUT 2/2023 | 3 pesakit dalam satu masa | 36 pt/year Prescribing Restriction: i. To be restricted to carbapenem-resistant Enterobacteriaceae (CRE) as an alternative to polymyxin. ii. Treatment initiated after proven susceptibility to ceftazidime/avibactam via C&S testing. iii. To be prescribed by Infectious Disease Specialist only | |||||||||||||||||||||||||
84 | 56 | Ceftaroline Fosamil 600mg Powder for concentrate | IP | A* | Medical | JKUT 1/23 | JKUT 1/23 | 3 pesakit dalam satu masa | 600mg BD FOR 5-14 Days | ||||||||||||||||||||||||
85 | 57 | Ceftolozane 100mg & Tazobactam 500mg Injcetion | IP | A* | Medical (ID) | JKUT 2/2025 | JKUT 2/2025 (+3) | 3 pesakit | |||||||||||||||||||||||||
86 | 58 | Chlorambucil 2mg Tablet | OP | A | Medical (Haematology) | JKUT 2/2023 (5) | 5 pesakit | 10mg daily for 1 week, repeat in 3 weeks for 6 cycles | |||||||||||||||||||||||||
87 | 59 | Chlorpromazine HCl 100mg Tablet | Largactil | IP | B | Anestesiology | JKUT 1/2022 (+120) | JKUT 1/2026 (LUAR JKUT OPEN) | OPEN | Indication: for agitation 25mg TDS x 5/7 | |||||||||||||||||||||||
88 | 60 | Ciclesonide 160mcg inhalation | Alvesco | OP | A* | Paediatric | JKUT 1/08 | JKUT 3/08 JKUT 1/17 (-15) JKUT 1/18 (-3) JKUT 1/20 (+2) JKUT 1/2025 (9) JKUT 1/2026 (LUAR JKUT +10) | 40 pesakit | 1 pesakit = 1 puff OD (6 can/tahun). Total = 72 cans/tahun | |||||||||||||||||||||||
89 | Pulmonology | JKUT 3/15 (5) | 5 pesakit | 1 pesakit = 1-4 puffs OD (1-2 cans/pt/month). Total = 120 cans/tahun | |||||||||||||||||||||||||||||
90 | 61 | Ciclosporin 25/100mg Capsule | Sandimmun Neoral | OP | A* | Dermatology | JKUT 3/13 | JKUT 1/18 (3) JKUT 2/19 (+3) | 8 pesakit | Indication : Cases of recalcitrant psoriasis and atopic eczema, Dose : 2.5 mg/kg/day in 2 divided doses increasing if there is no improvement after 4 weeks by 0.5 -1 mg/kg/month up to maximum 5 mg/kg/day | |||||||||||||||||||||||
91 | 62 | Ciclosporin 25 Capsule | Sandimmun Neoral | OP | A* | Medical (RHEUMATOLOGY) | JKUT 3/15 (1) | JKUT 1/17 (9) JKUT 2/2022 (+3) JKUT 1/2024 (+8) JKUT 1/2025 (+9) | 30 pesakit (Rheumatologi) | ||||||||||||||||||||||||
92 | Medical (Haematology) | JKUT 2/2023 (+2) | 2 pesakit (Hematologi) | Indication: severe aplastic anemia Dose 3mg/kg BD x 6 months | |||||||||||||||||||||||||||||
93 | Pulmonology | JKUT 1/19 (2) | 2 pesakit | Patients are transferred from Hospital Ampang Lung Transplant Clinic in 2019. | |||||||||||||||||||||||||||||
94 | Dermatology | JKUT 2/2025 | JKUT 2/2025 (+5) | 5 pesakit | |||||||||||||||||||||||||||||
95 | 63 | Cinacalcet Hydrochloride 25mg tablet | Nephrology | JKUT 2/2025 (+3) JKUT 1/2026 (+5) | 45 pesakit | ||||||||||||||||||||||||||||
96 | 64 | Ciclosporin Ophthalmic Emulsion 0.05% | Restasis | OP | A* | Ophtalmology | JKUT 1/2024 | 25 PESAKIT JKUT 1/2026 (LUAR JKUT +15) | 40 PESAKIT | 1 DROP BD ON BOTH EYES | |||||||||||||||||||||||
97 | 65 | Cisatracurium Besylate 2mg/ml Injection | Regpara | OP | A* | Nephrology | JKUT 2/19 (+6) | JKUT 1/20 (+2) JKUT 2/2021 (+5) JKUT 1/2022 (+5) JKUT 1/2023 (+5) JKUT 2/2023 (+7) JKUT 1/2024 (+5) JKUT 1/2025(+5) | 35 Pesakit | ||||||||||||||||||||||||
98 | IP | A* | KAP | JKUT 2/2024 (+50) | 50 pesakit | 2 vials/ pt - for patient who has chronic lung disease and end stage renal failure - to be kept as stock in Pusat Jantung | |||||||||||||||||||||||||||
99 | 66 | Clobazam 10mg Tablet | Frisium | OP | A* | Pediatrics | JKUT 3/13 | JKUT 1/2025 (+8) JKUT 2/2025 (+10) JKUT 1/2026 (LUAR JKUT +5) | 20 pesakit | ||||||||||||||||||||||||
100 | 67 | Clozapine 25mg & 100mg Tablet | Clozaril | OP | A | Psychiatry | JKUT 2/18 | JKUT 1/20 (+3) JKUT 2/20 (+3) JKUT 1/2021 (2) JKUT 2/2022 (+5) JKUT 2/2024 (OPEN) | OPEN | Initial: 12.5mg od/bd, THEN 25-50mg up to 300mg daily Max: 900mg daily |